DEA Reviews Application From Medi-Physics
January 31, 2025
January 31, 2025
WASHINGTON, Jan. 31 (TNSFR) -- The Drug Enforcement Administration has announced that Inc. DBA GE Healthcare has applied for registration as an importer of Schedule II controlled substances. The Illinois-based company seeks authorization to import cocaine and ecgonine derivatives for use in the manufacture of a diagnostic product and reference standards.
The DEA's review process ensures that such controlled substances are used strictly for medical and scientific purposes whil . . .
The DEA's review process ensures that such controlled substances are used strictly for medical and scientific purposes whil . . .